Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALStandard

LIQUID E-Z-PAQUE

BARIUM SULFATE

Standard Dose
60%
Max Dose
Refer to approved labeling
Primary Use
Review priority: N/A Marketing status: Prescription
Summary

Approval overview LIQUID E-Z-PAQUE is listed in Drugs@FDA under application 208143 (NDA).

Review priority: N/A Marketing status: Prescription Active ingredient BARIUM SULFATE Form and strength SUSPENSION;ORAL - 60% Sponsor BRACCO Submission history Latest submission status date: 2022-03-10 00:00:00.

Structured Monograph

Clinical summary

Approval overview LIQUID E-Z-PAQUE is listed in Drugs@FDA under application 208143 (NDA). Review priority: N/A Marketing status: Prescription Active ingredient BARIUM SULFATE Form and strength SUSPENSION;ORAL - 60% Sponsor BRACCO Submission history Latest submission status date: 2022-03-10 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: N/A

Interaction Notes

  • No interaction notes stored yet.
LIQUID E-Z-PAQUE (BARIUM SULFATE) | Drug Monograph | MedicHelpline